Coronary Disease Clinical Trial
Official title:
A Randomized Comparison of TR Band Hemostatic Compression Patterns After Transradial Coronary Intervention
The purpose of the study is to investigate the protective effects of short term TR Band compression on transradial coronary occlusion after transradial coronary intervention.
Radial artery occlusion (RAO), an infrequent but serious complication after transradial
coronary intervention (TRI), prevents subsequent use of the same radial artery for coronary
angiography and intervention. Comparing to the overseas counterparts, most Chinese medical
workers put more emphasis on prevention of postoperative puncture site bleeding, so longer
compression hemostasis time is applied but this prolonged compression may underestimate or
even ignore an increasing risk of RAO. Therefore, this study intends to compare short term
TR Band compression and the routine long term one on transradial coronary occlusion after
transradial coronary intervention.
Participants allocated to the control group will receive a routine long term postoperative
puncture site compression via TR Band. In control group, TR Band deflation is commenced at
the 2nd hour with successive 5 mL air released at 2 hours intervals until the bladder was
empty at the 6th hour, and the TR Band is removed at the 24th hour.
Participants allocated to the experimental group will receive a short term postoperative
puncture site compression via TR Band. In experimental group, TR Band deflation is commenced
at the 1st hour with 3 mL air released, and at the 2nd hour with 5ml, and at the 3rd hour
with the remainder air in the bladder, and the TR Band is removed at the 12th hour.
At the 24th hour, RAO incidence, postoperative puncture site bleeding incidence and patient
comfort level will be evaluated.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Completed |
NCT05672862 -
International Post-PCI FFR Extended Registry
|
||
Completed |
NCT04492423 -
VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
|
||
Completed |
NCT01205776 -
EXCEL Clinical Trial
|
N/A | |
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Completed |
NCT00046410 -
Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting
|
N/A | |
Recruiting |
NCT04390672 -
Multivessel TALENT
|
N/A | |
Completed |
NCT02948517 -
Time Restricted Feeding for Weight Loss and Cardio-protection
|
N/A | |
Completed |
NCT02784873 -
High Intensity Interval Training in UK Cardiac Rehabilitation Programmes
|
N/A | |
Recruiting |
NCT02859480 -
Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI
|
Phase 4 | |
Withdrawn |
NCT02418143 -
A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope
|
||
Completed |
NCT02382731 -
Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction
|
N/A | |
Completed |
NCT02510547 -
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
|
Phase 4 | |
Recruiting |
NCT01681381 -
Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization
|
N/A | |
Completed |
NCT02248415 -
Administration of Warm Blood Cardioplegia With or Without Roller Pump
|
N/A | |
Recruiting |
NCT01207167 -
Mediators of Atherosclerosis in South Asians Living in America
|
||
Completed |
NCT02088138 -
Functional Electrical Stimulation in Cardiac Patients
|
N/A | |
Completed |
NCT02133807 -
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
|
Phase 3 | |
Completed |
NCT02173067 -
Anesthesia With Epinephrine in Diabetes Patients is Safe and Effective
|
N/A | |
Completed |
NCT00531011 -
EXecutive RCT: Evaluating XIENCE V® in a Multi Vessel Disease
|
Phase 4 |